Conference and Workshops
2-5 October, 2018
Boston, USA

Cofactor

Cofactor Genomics, Inc. is a translational and clinical assay company using RNA as the foundation for providing a better understanding of disease. We’ve invested in the development of proprietary databases focused on (1) cancer-specific gene expression and (2) unique immune cell RNA expression fingerprints. These databases enable us to quantify complex molecular profiles, and provide comprehensive characterization of immune response in all solid tumor tissues. Cofactor leverages our expertise in high-throughput sequencing, CAP-accredited laboratory, and unique machine-learning algorithms to deliver candidate biomarkers in an easy-to-interpret report.